Organization
Fosun Pharma USA, Inc
1 abstract
Abstract
FS-1502 in HER2-positive advanced breast cancer: Results from an open-label, phase 1 study.Org: Beijing Fosun Pharmaceutical Research and Development Co., Ltd., Shanghai, China, Shanghai Fosun Pharmaceutical Development Co., Ltd., Fosun Pharma USA, Inc,